Avian Influenza

A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults

Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart

Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology

Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly

2013/2017 H7N9 Prime-Boost Interval

2017 A/H7N9 IIV Revaccination

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4

H5N1 With or Without Topical Aldara in Healthy Adults

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults

A Safety and Immunogenicity Study of IVACFLU-A/H5N1

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine